Navigation Links
Baxa Announces Colorado BioScience Association Sponsorship
Date:5/1/2008

ENGLEWOOD, Colo., May 1 /PRNewswire/ -- Baxa Corporation announces its 2008 sponsorship for the Colorado BioScience Association (CBSA). CBSA Board Chair Jack Wheeler (founder of MicroPhage Inc.) recognized Baxa, along with the other 2008 Association sponsors, during the CBSA Annual All-Member Meeting held April 29th at the University Club in Denver. Baxa Corporation has been a member of the CBSA since its inception. Company founder Brian Baldwin was one of the founders and the first President of its predecessor organization, the Colorado Medical Device Association.

"The Colorado BioScience Association works on behalf of our industry at both the state and national level," notes Baxa Chairman and CEO Greg Baldwin of the sponsorship. "We support them because their work to grow the industry makes Colorado, and especially the Denver metropolitan area, a better place for all bioscience and medical device companies to do business."

Through the years, Baxa has provided support for CBSA events and activities without a formal sponsorship grant. The company's investment underlines its support of CBSA initiatives for industry growth, networking and professional education, as well as for the role it has played in promoting Colorado and Denver as leaders in the technology industry. In a business competitiveness report from 2004 cited on the CBSA Web site, Colorado is ranked as the #5 state and Denver as the #5 city for economic development and commitment to technology growth (http://www.cobioscience.com/factsheet.php).

In addition to publicizing the accomplishments of state bioscience companies, the Colorado BioScience Association works to develop partnerships with Colorado's life science research institutions to increase the commercialization of Colorado-based technologies. As the industry's professional voice, CBSA fosters industry growth and investment. The organizational is also
'/>"/>

SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Anesiva Announces First Quarter 2008 Financial Results Conference Call and Webcast
3. Anesiva Announces Expansion of Zingo Agreement in Europe
4. Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
5. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center
7. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
8. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
9. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
10. BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board
11. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Houston, TX (PRWEB) December 17, 2014 ... marketing and administration for Stoller Group. In this position, ... Stoller Group, on administrative matters, develop marketing strategy and ... and services. , “Achim has tremendous knowledge and ... president of Stoller Group. “His experience and innovative thinking ...
(Date:12/17/2014)... December 17, 2014 Gene synthesis ... it has entered into a technology access and ... to apply DNA2.0’s proprietary protein engineering technology, known ... , “We are extremely excited that the global ... This proprietary bioengineering technology has now been ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
(Date:12/15/2014)... 15, 2014  GlassesOff Inc. (OTCBB: GLSO) announced today ... an independent director of the Company,s Board of Directors. ... served as its CEO until its acquisition by ... million transaction. Recognized as the inventor of the first ... provided Wi-Fi -based RFID solutions focused on improving operational ...
Breaking Biology Technology:Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3
... YORK and SAN DIEGO, Dec. 31 Forest,Laboratories, ... Inc. (Nasdaq: CYPB ),announced that they have ... U.S. Food and Drug Administration (FDA) for milnacipran, ... of fibromyalgia,syndrome (FMS)., (Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ...
... (NYSE: TMO ) announced that it will present ... the Westin St. Francis,Hotel in San Francisco, Calif. The ... p.m. (PST)., Marijn E. Dekkers, president and chief ... of the company and discuss its,expectations for future performance., ...
... Pafuramidine on Clinical Hold ... Schedule Zensana(TM) ... N.J., Dec. 28 Par,Pharmaceutical Companies, Inc. (NYSE: ... the,development status of its three, in-licensed, proprietary pipeline,products: ...
Cached Biology Technology:Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome 2Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome 3Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome 4Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 3Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 4Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 5
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... MOUNTAIN VIEW, Calif. , Nov. 20, 2014 /PRNewswire/ ... for higher driver efficiency are piloting the North American ... the number of accidents growing, gesture recognition systems that ... will make a mark in the industry. ... of the Automotive Gesture Recognition Market in ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... robust, efficient method of using hydrogen as a fuel source. ... converted to electricity in a fuel cell and because it is ... a gas, it can only be stored in high pressure or ... of hydrogen, "if you got into a wreck, you,d have a ...
... CORVALLIS, Ore. As wolf populations grow in parts of ... value in aiding broader ecosystem recovery but a new ... could play an important role in helping to save other ... Bulletin, scientists suggest that a key factor in the Canada ...
... CAMBRIDGE, Mass. -- New research from MIT suggests that ... and only language, a finding that marks a major ... sophisticated mental functions. Functional specificity, as it,s known ... parts of the brain handle distinct tasks. Scientists have ...
Cached Biology News:Wolves may aid recovery of Canada lynx, a threatened species 2Localizing language in the brain 2Localizing language in the brain 3Localizing language in the brain 4
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Feline Rhinotracheitis Virus...
Rabbit anti-NFkB p105/p50 (Ser529) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: